相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
Patricia S. Grace et al.
FRONTIERS IN IMMUNOLOGY (2021)
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime-MVA85A boost in healthy UK adults
Morven Wilkie et al.
VACCINE (2020)
A phase lb randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa
Linda-Gail Bekker et al.
ECLINICALMEDICINE (2020)
Latent TB Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground
Martin Rao et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection
Ryoji Maekura et al.
MICROBIOLOGY AND IMMUNOLOGY (2019)
A Case for Antibodies as Mechanistic Correlates of Immunity in Tuberculosis
Jeffrey Y. Kawahara et al.
FRONTIERS IN IMMUNOLOGY (2019)
Characteristic profile of antibody responses to PPD, ESAT-6, and CFP-10 of Mycobacterium tuberculosis in pulmonary tuberculosis suspected cases in Surabaya, Indonesia
Desak Nyoman Surya Suameitria Dewi et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2019)
Immunogenicity and Safety of the M72/AS01E Candidate Vaccine Against Tuberculosis: A Meta-Analysis
Zhenhua Ji et al.
FRONTIERS IN IMMUNOLOGY (2019)
Emerging Themes for the Role of Antibodies in Tuberculosis
Andy C. Tran et al.
IMMUNE NETWORK (2019)
Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine
Scott G. Hansen et al.
NATURE MEDICINE (2018)
Prevention of M-tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
E. Nemes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals
Fekadu Abebe et al.
PLOS ONE (2018)
Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from disease
Delia Goletti et al.
RESPIROLOGY (2018)
PPE17 (Rv1168c) protein of Mycobacterium tuberculosis detects individuals with latent TB infection
Philip Raj Abraham et al.
PLOS ONE (2018)
Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
Andre G. Loxton et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design
Mohsen Karbalaei Zadeh Babaki et al.
MICROBIAL PATHOGENESIS (2017)
New synthetic lipid antigens for rapid serological diagnosis of tuberculosis
Alison Jones et al.
PLOS ONE (2017)
Field evaluation of a blood based test for active tuberculosis in endemic settings
Aasia Khaliq et al.
PLOS ONE (2017)
Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis
Hao Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Detection of a combination of serum IgG and IgA antibodies against selected mycobacterial targets provides promising diagnostic signatures for active TB
Dolapo O. Awoniyi et al.
ONCOTARGET (2017)
Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine
Rafael Prados-Rosales et al.
PLOS PATHOGENS (2017)
RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial
Gemma Moncunill et al.
FRONTIERS IN IMMUNOLOGY (2017)
Evaluation of Rv0220, Rv2958c, Rv2994 and Rv3347c of Mycobacterium tuberculosis for serodiagnosis of tuberculosis
Xiaolong You et al.
MICROBIAL BIOTECHNOLOGY (2017)
Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda
Priya B. Shete et al.
PLOS ONE (2017)
A Functional Role for Antibodies in Tuberculosis
Lenette L. Lu et al.
CELL (2016)
Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis
Natalie Zimmermann et al.
EMBO MOLECULAR MEDICINE (2016)
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
Elisa Petruccioli et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Blood and urine inducible protein 10 as potential markers of disease activity
L. Petrone et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction
Tingting Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults
Alice Minhinnick et al.
VACCINE (2016)
T-cell activation is an immune correlate of risk in BCG vaccinated infants
Helen A. Fletcher et al.
NATURE COMMUNICATIONS (2016)
Recent developments in the diagnosis and management of tuberculosis
Giorgia Sulis et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2016)
Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis
Timothy Lahey et al.
PLOS ONE (2016)
Serological diagnosis of pulmonary Mycobacterium tuberculosis infection by LIPS using a multiple antigen mixture
Peter D. Burbelo et al.
BMC MICROBIOLOGY (2015)
B cells and antibodies in the defense against Mycobacterium tuberculosis infection
Jacqueline M. Achkar et al.
IMMUNOLOGICAL REVIEWS (2015)
Role of B Cells in Mucosal Vaccine-Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis
Amandeep K. Khera et al.
JOURNAL OF IMMUNOLOGY (2015)
First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults
Angelique Kany Kany Luabeya et al.
VACCINE (2015)
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting
Adam Penn-Nicholson et al.
VACCINE (2015)
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies
Ekaterina V. Kurbatova et al.
LANCET RESPIRATORY MEDICINE (2015)
Live Oral Salmonella enterica Serovar Typhi Vaccines Ty21a and CVD 909 Induce Opsonophagocytic Functional Antibodies in Humans That Cross-React with S. Paratyphi A and S. Paratyphi B
Rezwanul Wahid et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Evaluation of Antigen Detection Test (Chromatographic Immunoassay): Potential to Replace the Antibody Assay Using Purified 45-kDa Protein for Rapid Diagnosis of Tuberculosis
Alireza Hadizadeh Tasbiti et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2014)
Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets
Ralf Baumann et al.
JOURNAL OF INFECTION (2014)
Tuberculosis Risk in Patients Treated with Non-Anti-Tumor Necrosis Factor-α (TNF-α) Targeted Biologics and Recently Licensed TNF-α Inhibitors: Data from Clinical Trials and National Registries
Fabrizio Cantini et al.
JOURNAL OF RHEUMATOLOGY (2014)
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
Michele D. Tameris et al.
LANCET (2013)
Serodiagnostic markers for the prediction of the outcome of intensive phase tuberculosis therapy
Ralf Baumann et al.
TUBERCULOSIS (2013)
The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation
Nesty Olivares et al.
PATHOGENS AND DISEASE (2013)
MprA and DosR Coregulate a Mycobacterium tuberculosis Virulence Operon Encoding Rv1813c and Rv1812c
Daniel J. Bretl et al.
INFECTION AND IMMUNITY (2012)
DOTS for TB relapse in India: A systematic review
Gulrez Shah Azhar
LUNG INDIA (2012)
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Maya H. Buch et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Immunochromatographic IgG/IgM Test for Rapid Diagnosis of Active Tuberculosis
Walid Ben-Selma et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis
Sucharitha Balu et al.
JOURNAL OF IMMUNOLOGY (2011)
The MycoBrowser portal: A comprehensive and manually annotated resource for mycobacterial genomes
Adamandia Kapopoulou et al.
TUBERCULOSIS (2011)
Commercial Serological Tests for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis: An Updated Systematic Review and Meta-Analysis
Karen R. Steingart et al.
PLOS MEDICINE (2011)
IP-10 detection in urine is associated with lung diseases
Angela Cannas et al.
BMC INFECTIOUS DISEASES (2010)
Identification of Mycobacterium tuberculosis Antigens of High Serodiagnostic Value
Gregory C. Ireton et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Evaluation of the diagnostic value of measuring IgG, IgM, and IgA antibodies to mycobacterial A60 antigen in active tuberculosis
Walid Ben-selma et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Increased IgG1, IFN-γ, TNF-α and IL-6 responses to Mycobacterium tuberculosis antigens in patients with Tuberculosis are lower after chemotherapy
Ana Marcia M. Mattos et al.
INTERNATIONAL IMMUNOLOGY (2010)
Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis
David J. Horne et al.
LANCET INFECTIOUS DISEASES (2010)
Prophylactic effect of administration of human gamma globulins in a mouse model of tuberculosis
Nesty Olivares et al.
TUBERCULOSIS (2009)
Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer
Timothy J. McDonnell et al.
BMC MEDICAL GENOMICS (2008)
Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice
Evelyn Guirado et al.
MICROBES AND INFECTION (2006)
Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies
S de Vallière et al.
INFECTION AND IMMUNITY (2005)
Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice
E Roy et al.
INFECTION AND IMMUNITY (2005)
Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis
PJ Cardona et al.
VACCINE (2005)
Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs
A Williams et al.
IMMUNOLOGY (2004)
A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab′)2 fragment prolong survival of mice infected with Mycobacterium tuberculosis
B Hamasur et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis
M Parra et al.
INFECTION AND IMMUNITY (2004)
The heparin-binding haemagglutinin of M-tuberculosis is required for extrapulmonary dissemination
K Pethe et al.
NATURE (2001)
分享论文
